Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Bioanalytical Systems, Inc. (BASI) To Collaborate With DSI On Groundbreaking New Study 0 comments
    Dec 10, 2012 2:37 PM | about stocks: BASI

    Friday, Bioanalytical Systems announced a collaboration with Data Sciences International (DSI) to conduct a pioneering study that combines Bioanalytical Systems' Culex-L automated sampling system with PhysioTel Digital, DSI's latest large animal telemetry technology. DSI is a biomedical research company with its focus on preclinical systems physiology and pharmacology.

    In this groundbreaking study, BASi's Culex-L automated in vivo sampling system will simultaneously gather biological samples at pre-programmed intervals while DSI telemetry devices collect heart rate, blood pressure, and other cardiovascular data. The gathering of these various types of data formerly required two separate experiments and allowed only discontinuous data collection.

    Combining Culex with telemetry will result in reductions in cost, number of test subjects, and subject test levels for the automated blood sampling and telemetry (ABST) system, as well delivery of better data. This will collectively lead to better decision making. The study will lay the groundwork for additional safety pharmacology studies to further complement BASi's CRO services expertise.

    These efforts are in response to customer requests for additional and improved pharmacokinetic data, which is crucial for early decision-making in the drug discovery process. Joining DSI's telemetry with BASi's automation is a natural fit.

    Bioanalytical Systems is a pharmaceutical development company engaged in providing contract research services and monitoring instruments to the world's premier drug development companies and medical research organizations. The company is focused on the development of innovative services and products that enhance efficiency and decrease the cost of taking a new drug to market.

    For more information, visit www.BASinc.com

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: BASI
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.